- Pittsburgh Nexium and Prilosec Attorneys
Pittsburgh Nexium and Prilosec Attorneys
Several studies and thousands of anecdotal cases link proton pump inhibitors (PPIs) such as Nexium and Prilosec—popular for the treatment of heartburn, acid reflux, and related conditions—with serious kidney complications. The manufacturers of these medications face thousands of lawsuits consolidated into a mass tort in a New Jersey court.
The dangerous and defective drug lawyers from Berger and Green are now reviewing PPI and kidney complications cases. Call or text us today at (412) 661-1400 to get started. Our consultations are always free, and you pay nothing unless we recover compensation for you.
For a free legal consultation with a Proton Pump Inhibitors Lawsuit lawyer serving Pittsburgh, call 412-661-1400
Understanding the Link Between PPIs and Serious Kidney Complications
Proton pump inhibitors are effective against both the pain and the damage caused by chronic heartburn, acid reflux, and gastroesophageal reflux disease (GERD). By preventing this damage from occurring, PPIs can reduce the risk of cancer and other problems in the esophagus, throat, and upper gastrointestinal tract.
They are available as prescription drugs for long-term use or over the counter in smaller dosages for short-term use. The U.S. Food and Drug Administration (FDA) has given drug approvals to many companies to manufacture and market their own PPIs.
Unfortunately, research conducted by several organizations and published separately in renowned medical journals uncovered a dark side to the medications in 2016. These PPIs all seemed to have a link to an increased risk of kidney complications. This includes:
- A February 2016 study published in JAMA Internal Medicine.
- An October 2016 research review published in the Journal of Nephrology.
- An October 2016 study published in the Journal of the American Society of Nephrology.
The study in the Journal of the American Society of Nephrology, in fact, found that long-term use of a prescription-strength PPI drug led to:
- Doubled the risk of kidney failure
- A 26% increased risk of developing chronic kidney disease
These are serious complications and may require ongoing care, lead to impairment and disability, require dialysis or transplant, and even lead to death.
Pittsburgh Proton Pump Inhibitors Lawsuit Lawyer Near Me 412-661-1400
Recoverable Damages in a Proton Pump Inhibitor Lawsuit
When a drug manufacturer creates, makes, and/or markets a product that causes preventable injuries to those who use it, they may be accountable for any damages in the same way any manufacturer is liable for defective products they produce. However, when it comes to dangerous or defective drugs, the stakes are often higher.
Not only can a dangerous drug cause injuries that require medical care, but they can cause chronic, lifelong illness and terminal medical conditions. In the case of PPI inhibitors and kidney complications, some of the recoverable damages could include:
- Medical care costs for diagnosis and treatment of kidney complications
- Ongoing care costs for dialysis and other treatments
- Pain and suffering damages for physical pain and emotional anguish
- Out-of-pocket expenses related to kidney condition or treatment
- Punitive damages for failure to disclose the danger
- Punitive damages for failure to protect users from serious injuries
- Wrongful death damages, if they passed away because of kidney failure or disease
If Berger and Green handles your PPI lawsuit, we can help you document your range of related damages to maximize the payout you could receive. We will collect evidence and build a strong case to prove the expenses and losses you suffered because of this type of dangerous drug.
Status of the Proton Pump Inhibitor Lawsuit in June 2019
Because of the large number of people who experienced kidney-related complications after taking these popular heartburn drugs, the Judicial Panel on Multidistrict Litigation decided to consolidate hundreds of lawsuits related to these medications into Proton-Pump MDL 2789. This multidistrict litigation (MDL) is currently in-progress in a New Jersey federal court.
The lawsuits against the makers of Nexium and Prilosec, as well as many other drug companies who produce PPIs, accuse these manufacturers of failing to adequately warn users of the risk of serious kidney damage.
Many of those with pending claims in this MDL need dialysis or a kidney transplant or have already undergone a kidney transplant. Others lost a loved one to kidney-related diseases or complications.
Even though this MDL is already underway, there may still be time to file your claim and join. Reach out to the defective drug team at Berger and Green today by calling or texting (412) 661-1400.
Complete a Free Case Evaluation form now
Berger and Green Can Help You Hold the Drug Companies Liable
If you suffered kidney disease, kidney failure, or other serious kidney complications after taking proton pump inhibitors, you may be eligible to pursue compensation from the drug manufacturers. Let our team of dangerous drug attorneys review your case for free. We offer complimentary, no-obligation consultations and can help you understand your rights.
If you decide to pursue your case, reach out to our team, and we can help. We may be able to file a lawsuit on your behalf or join the MDL already in progress. You may also qualify for Social Security Disability for renal diseases if your condition prevents you from working or if you require a transplant.
Talk to a Proton Pump Inhibitors Lawsuit Lawyer About Your Case
Drug companies should not be able to develop and market dangerous drugs that cause serious and even deadly complications for those who take them. If you or a loved one suffered serious kidney-related complications and also took PPIs, Berger and Green is here to help.
Call or text our team today at (412) 661-1400. We can evaluate the strength of your case, explain your options, and take legal action on your behalf. Let a proton pump inhibitor lawsuit lawyer pursue the payout you deserve if you suffered complications from a PPI drug.